These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1343089)

  • 41. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-interferon in hairy cell leukemia: an initial Indian experience.
    Malhotra H; Advani SH; Gopal R; Saikia TK; Nadkarni KS; Pai VR; Nair CN
    J Assoc Physicians India; 1992 Mar; 40(3):159-61. PubMed ID: 1634479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
    Kloke O; May D; Wandl U; Niederle N
    Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
    Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
    J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demonstrated Benefit of Continuous Interferon-Alpha-2b Therapy in Hairy Cell Leukemia. A Two-Year Follow-Up.
    Braide I; Westin J; Hasselbalch H; Hippe E; Lisse I; Röckert L; Swolin B; Zador G
    Leuk Lymphoma; 1991; 5(1):23-31. PubMed ID: 27463206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA; Brady J; Kidd P; Fefer A
    Cancer Treat Rep; 1985; 69(7-8):791-3. PubMed ID: 4016788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
    Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
    Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Low-dose alpha-interferon treatment of hairy cell leukemia].
    von Wussow P; Freund M; Block B; Diedrich H; Schmoll H; Poliwoda H; Deicher H
    Klin Wochenschr; 1987 Jul; 65(14):681-4. PubMed ID: 3626433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hairy cell leukemia: splenectomy after alpha 2b-interferon therapy.
    Pangalis GA; Boussiotis VA; Kittas C; Panayiotidis PG; Loukopoulos D; Fessas P; Mitsoulis-Mentzikoff C
    Blood; 1991 Sep; 78(5):1385. PubMed ID: 1878598
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2b.
    Aul C; Gattermann N; Schneider W
    Eur J Haematol; 1991 Jan; 46(1):11-6. PubMed ID: 1988303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low doses of alpha 2B interferon in the treatment of hairy cell leukemia: results of treatment and mean follow-up at 18 months in 13 patients.
    Santagati G; Nastasi G; Porta C; Moroni M; Santagati C; Casagranda I; Bobbio-Pallavicini E; Cosimi MF
    Pathologica; 1994 Feb; 86(1):66-9. PubMed ID: 8072805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
    Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):13-7. PubMed ID: 3589701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Splenectomy for hairy cell leukaemia.
    Ingoldby CJ; Ackroyd N; Catovsky D; Spencer J
    Clin Oncol; 1981 Dec; 7(4):325-31. PubMed ID: 7318275
    [No Abstract]   [Full Text] [Related]  

  • 55. Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986.
    Spielberger RT; Mick R; Ratain MJ; Golomb HM
    Leuk Lymphoma; 1994; 14 Suppl 1():89-93. PubMed ID: 7820060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.
    Spiegel RJ; Jacobs SL; Treuhaft MW
    J Interferon Res; 1989 Sep; 9 Suppl 1():S17-24. PubMed ID: 2553829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia.
    Smalley RV; Connors J; Tuttle RL; Anderson S; Robinson W; Whisnant JK
    Am J Hematol; 1992 Sep; 41(1):13-8. PubMed ID: 1503094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to interferon-alpha 2 in patients treated with interferon-alpha 2 for hairy cell leukemia.
    Bekisz JB; zur Nedden DL; Enterline JC; Zoon KC
    J Interferon Res; 1989 Sep; 9 Suppl 1():S1-7. PubMed ID: 2809275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three years' continuous low-dose interferon-alpha treatment of hairy-cell leukemia: evaluation of response and maintenance dose.
    Goldmann B; Sonnen R; Kuse R
    Eur J Haematol; 1993 Sep; 51(3):177-8. PubMed ID: 8405334
    [No Abstract]   [Full Text] [Related]  

  • 60. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
    Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
    Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.